The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
Open accessAbstract
BACKGROUND: KRAS mutation is a negative predictive factor for treatment with anti-epidermal growth factor receptor antibody in metastatic colorectal cancer (CRC). KRAS mutation analysis is usually performed on primary tumour tissue because metastatic tissue is often not available. However, controversial data are available on the concordance of test results between primary tumours and corresponding metastases. We assessed the concordance of KRAS mutation status in a study of 305 primary colorectal tumours and their corresponding liver metastases. METHODS: Patients with histologically confirmed CRC who underwent surgical resection of the primary tumour and biopsy or surgical resection of the corresponding liver metastasis were included. KRAS mutation analysis was performed for codons 12 and 13. RESULTS: KRAS mutation was detected in 108 out of 305 primary tumours (35.4%). In 11 cases (3.6%), we found a discordance between primary tumour and metastasis: 5 primary tumours had a KRAS mutation with a wild-type metastasis, 1 primary tumour was wild type with a KRAS mutation in the metastasis, and in 5 cases the primary tumour and the metastasis had a different KRAS mutation. CONCLUSION: We observed a high concordance of KRAS mutation status of 96.4% (95% CI 93.6-98.2%) between primary colorectal tumours and their corresponding liver metastases. In only six patients (2.0%; 95% CI 0.7-4.2%), the discordance was clinically relevant. In this largest and most homogenous study to date, we conclude that both primary tumours and liver metastases can be used for KRAS mutation analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“discordance in KRAS mutation status is rare in distant organ metastases (less than 10%) [52,53]”
From The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives (2025) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Amado, R. G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D. J., Juan, T., Sikorski, R., Suggs, S., Radinsky, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7116 · Cited by 3,207
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591 · cited 1×
“Efficacy of anti-EGFR therapy was suggested to be further restricted to patients with BRAF wild-type tumours (Di Nicolantonio et al, 2008).”
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Tol, J., Koopman, M., Cats, A., Rodenburg, C. J., Creemers, G. J., Schrama, J. G., Erdkamp, F., Vos, A. H., van Groeningen, C. J., Sinnige, H. A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808268 · Cited by 1,347
Self-citationParallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2627 · Cited by 1,161
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
Benvenuti, S., Sartore-Bianchi, A., Di Nicolantonio, F., Zanon, C., Moroni, M., Veronese, S., Siena, S., & Bardelli, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4158 · Cited by 830
De Roock, W., Jonker, D. J., Di Nicolantonio, F., Sartore-Bianchi, A., Tu, D., Siena, S., Lamba, S., Arena, S., Frattini, M., Piessevaux, H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1535 · Cited by 748
Cited by
Sorted by citations
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Self-citationColon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Arain, M. A., Chen, Y., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D. A., Farkas, L. M., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0012 · Cited by 1,737
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A. E., ELIAS, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,612
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Cederquist, L., Chan, E., Chen, Y., Cooper, H. S., Deming, D. A., Engstrom, P. F., Enzinger, P. C., Fichera, A., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0036 · Cited by 1,333
Tumour heterogeneity in the clinic
Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,231
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Thierry, A. R., Mouliere, F. C., Messaoudi, S. E., Mollévi, C., Lopez‐Crapez, E., Rolet, F., Gillet, B., Gongora, C., Dechelotte, P., Robert, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3511 · Cited by 687
Taly, V., Pekin, D., Benhaïm, L., Kotsopoulos, S. K., Corre, D. L., Li, X., Atochin, I., Link, D. R., Griffiths, A. D., Pallier, K., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206359 · Cited by 511
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Adam, M. A., Chang, G. J., Chen, Y., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D. A., Garrido‐Laguna, I., et al. (2024) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2024.0029 · Cited by 433
Vauthey, J., Zimmitti, G., Kopetz, S., Shindoh, J., Chen, S. S., Andreou, A., Curley, S. A., Aloia, T. A., & Maru, D. M. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a5025a · Cited by 379
Brannon, A. R., Vakiani, E., Sylvester, B. E., Scott, S. N., McDermott, G. C., Shah, R. H., Kania, K., Viale, A. J., Oschwald, D. M., Vacic, V., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0454-7 · Cited by 375
The Genetic Basis for Cancer Treatment Decisions
Dancey, J. E., Bedard, P. L., Onetto-Pothier, N., & Hudson, T. J. (2012) · Cell · doi:10.1016/j.cell.2012.01.014 · Cited by 345
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
Timar, J., & Kashofer, K. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09915-5 · Cited by 334
Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas
Vakiani, E., Janakiraman, M., Shen, R., Sinha, R., Zeng, Z., Shia, J., Cercek, A., Kemeny, N. E., D'Angelica, M. I., Viale, A. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2994 · Cited by 288
Granados-Romero, J. J., Valderrama-Treviño, A. I., Contreras-Flores, E., Barrera‐Mera, B., Enríquez, M. H., Uriarte-Ruíz, K., Ceballos-Villalva, J. C., Estrada-Mata, A. G., Rodríguez, C. A., & Arauz-Peña, G. (2017) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20174914 · Cited by 294
Colorectal liver metastases: Current management and future perspectives
Martin, J. L., Petrillo, A., Smyth, E. C., Shaida, N., Khwaja, S. A., Cheow, H. K., Duckworth, A., Heister, P. M., Praseedom, R., Jah, A., et al. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i10.761 · Cited by 294
Circulating biomarkers for early detection and clinical management of colorectal cancer
Marcuello, M., Vymetalkova, V. P., Neves, R. P., Durán-Sanchón, S., Vedeld, H. M., Tham, E., van Dalum, G., Flügen, G., García‐Barberán, V., Fijneman, R. J. A., et al. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.06.002 · Cited by 283
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
Molinari, C., Marisi, G., Passardi, A., Matteucci, L., De Maio, G., & Ulivi, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123733 · Cited by 262
S3-Leitlinie – Kolorektales Karzinom
Schmiegel, W., Buchberger, B., Follmann, M., Graeven, U., Heinemann, V., Langer, T. G., Nothacker, M., Porschen, R., Rödel, C. M., Rösch, T., et al. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-121106 · Cited by 247
Colorectal liver metastases: An update on multidisciplinary approach
Chow, F. C.-L., & Chok, K. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i2.150 · Cited by 236
Peeters, M., Douillard, J.-Y., Van Cutsem, E., Siena, S., Zhang, K., Williams, R., & Wiezorek, J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.1492 · Cited by 232
KRAS mutation testing in metastatic colorectal cancer.
Tan, C., & Du, X. (2012) · PubMed · doi:10.3748/wjg.v18.i37.5171 · Cited by 238
Khan, K. H., Cunningham, D., Werner, B., Vlachogiannis, G., Spiteri, I., Heide, T., Fernández-Mateos, J., Vatsiou, A. I., Lampis, A., Darvish-Damavandi, M., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0891 · Cited by 227
Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases
Brudvik, K. W., Kopetz, S., Li, L., Conrad, C. H., Aloia, T. A., & Vauthey, J.-N. (2015) · British journal of surgery · doi:10.1002/bjs.9870 · Cited by 214
Lord, A. C., D’Souza, N., Shaw, A., Rokan, Z., Moran, B. J., Abulafi, M., Rasheed, S., Chandramohan, A., Corr, A., Chau, I., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004499 · Cited by 212
Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
Boutin, A. T., Liao, W.-T., Wang, M., Hwang, S. S., Karpinets, T. V., Cheung, H., Chu, G. C., Jiang, S., Hu, J., Chang, K., et al. (2017) · Genes & Development · doi:10.1101/gad.293449.116 · Cited by 195
Grasselli, J., Élez, E., Caratù, G., Matito, J., Santos, C., Macarulla, T. M., Vidal, J., García, M. D. S., Viéitez, J. M., Páez, D., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx112 · Cited by 188
Tsilimigras, D. I., Ntanasis‐Stathopoulos, I., Bagante, F., Moris, D., Cloyd, J. M., Spartalis, E. D., & Pawlik, T. M. (2018) · Surgical Oncology · doi:10.1016/j.suronc.2018.05.012 · Cited by 177
Pragmatic issues in biomarker evaluation for targeted therapies in cancer
Gramont, A. D. E., Watson, S., Ellis, L. M., Rodon, J. A., Tabernero, J. M., de Gramont, A., & Hamilton, S. R. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.202 · Cited by 179
Kawaguchi, Y., Kopetz, S., Newhook, T. E., Bellis, M. D., Chun, Y. S., Tzeng, C.-W. D., Aloia, T. A., & Vauthey, J. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0863 · Cited by 173
Vermaat, J. S. P., Nijman, I. J., Koudijs, M. J., Gerritse, F. L., Scherer, S. J., Mokrý, M., Roessingh, W. M., Lansu, N. R., de Bruijn, E., van Hillegersberg, R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1965 · Cited by 153
Schmiegel, W., Scott, R. J., Dooley, S., Lewis, W., Meldrum, C. J., Pockney, P. G., Draganic, B. D., Smith, S., Hewitt, C., Phillimore, H., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12023 · Cited by 152
Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment
Garralda, E., Paz, K., Lopez-Casas, P. P., Jones, S., Katz, A. M., Kann, L. M., López‐Ríos, F., Sarno, F., Al‐Shahrour, F., Vasquez, D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3047 · Cited by 148
Kim, M. J., Lee, H. S., Kim, J. H., Kim, Y. J., Kwon, J. H., Lee, J., Bang, S., Park, K. U., Kim, D., Kang, S., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-347 · Cited by 144
Combined Mutation of Apc, Kras , and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer
Sakai, E., Nakayama, M., Oshima, H., Kouyama, Y., Niida, A., Fujii, S., Ochiai, A., Nakayama, K. I., Mimori, K., Suzuki, Y., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3303 · Cited by 133
Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
Hsu, H., Thiam, T. K., Lu, Y., Yeh, C. Y., Tsai, W., You, J. F., Hung, H., Tsai, C., Hsu, A., Chen, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8076 · Cited by 134
Calandri, M., Yamashita, S., Gazzera, C., Fonio, P., Veltri, A., Bustreo, S., Sheth, R. A., Yevich, S. M., Vauthey, J., & Odisio, B. C. (2018) · European Radiology · doi:10.1007/s00330-017-5273-2 · Cited by 130
Lord, A. C., D’Souza, N., Pucher, P. H., Moran, B. J., Abulafi, A. M., Wotherspoon, A. C., Rasheed, S., & Brown, G. M. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.027 · Cited by 127
Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression
Hsu, W.-H., LaBella, K. A., Lin, Y., Xu, P., Lee, R., Hsieh, C.-E., Yang, L., Zhou, A., Blecher, J. M., Wu, C.-J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1467 · Cited by 125
on behalf of the DeCoDe PET group, Goos, J. A. C. M., Coupé, V. M. H., Diosdado, B., Diemen, P. M. D., Karga, C., Beliën, J. A. M., Carvalho, B. G., van den Tol, M. P., Verheul, H. M. W., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.608 · Cited by 122
Wang, K., Russell, J. S., McDermott, J. D., Elvin, J. A., Khaira, D., Johnson, A., Jennings, T. A., Ali, S. M., Murray, M., Marshall, C. B., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2568 · Cited by 123
Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers
Lee, S. Y., Haq, F. U., Kim, D., Jun, C., Jo, H.-J., Ahn, S., & Lee, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090459 · Cited by 117
Normanno, N., Abate, R. E., Lambiase, M., Forgione, L., Cardone, C., Iannaccone, A., Sacco, A., Rachiglio, A. M., Martinelli, E., Rizzi, D., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx417 · Cited by 115
Biomarker concordance between primary colorectal cancer and its metastases
Bhullar, D., Barriuso, J., Mullamitha, S., Saunders, M. P., O’Dwyer, S., & Aziz, O. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.050 · Cited by 118
Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study.
Dinu, D., Dobre, M., Panaitescu, E., Bîrlă, R., Iosif, C., Hoara, P. A., Caragui, A., Boeriu, M., Constantinoiu, S. M., & Ardeleanu, C. M. (2014) · Europe PMC (PubMed Central) · Cited by 114
Thierry, A. R., Messaoudi, S. E., Mollévi, C., Raoul, J., Guimbaud, R., Pezet, D., Artru, P., Assénat, E., Borg, C., Mathonnet, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx330 · Cited by 114
Mao, C., Wu, X.-Y., Yang, Z.-Y., Threapleton, D. E., Yuan, J.-Q., Yu, Y.-Y., & Tang, J.-L. (2015) · Scientific Reports · doi:10.1038/srep08065 · Cited by 107
Mise, Y., Zimmitti, G., Shindoh, J., Kopetz, S., Loyer, E. M., Andreou, A., Cooper, A. B., Kaur, H., Aloia, T. A., Maru, D. M., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4042-6 · Cited by 104
Custodio, A., & Feliú, J. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.05.001 · Cited by 100
Baas, J. M., Krens, L. L., Guchelaar, H.-J., Morreau, H., & Gelderblom, H. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0024 · Cited by 89
Spindler, K. G., Pallisgaard, N., Andersen, R. F., & Jakobsen, A. K. M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28863 · Cited by 90
Margonis, G. A., Sasaki, K., Andreatos, N., Kim, Y., Merath, K., Wagner, D., Wilson, A., Buettner, S., Amini, N., Antoniou, E., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5609-1 · Cited by 88
Vignot, S., Besse, B., André, F., Spano, J., & Soria, J. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.05.002 · Cited by 90
Westwood, M. E., van Asselt, A. D. I., Ramaekers, B. L. T., Whiting, P. F., Joore, M. A., Armstrong, N., Noake, C., Ross, J., Severens, J. L., & Kleijnen, J. (2014) · Health Technology Assessment · doi:10.3310/hta18620 · Cited by 85
Tran, B., Brown, A. M. K., Bedard, P. L., Winquist, E., Goss, G. D., Hotte, S. J., Welch, S. A., Hirte, H. W., Zhang, T., Stein, L. D., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27817 · Cited by 83
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy
Teng, H., Huang, Y.-C., Lin, J., Chen, W., Lin, T., Jiang, J., Yen, C., Li, A. F., Wang, H., Chang, S., et al. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23063 · Cited by 82
Takeda, M., Yoshida, S., Inoue, T., Sekido, Y., Hata, T., Hamabe, A., Ogino, T., Miyoshi, N., Uemura, M., Yamamoto, H., et al. (2025) · Cancers · doi:10.3390/cancers17030428 · Cited by 82
Andreou, A., Kopetz, S., Maru, D. M., Chen, S. S., Zimmitti, G., Brouquet, A., Shindoh, J., Curley, S. A., Garrett, C. R., Overman, M. J., et al. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31826b4dcc · Cited by 79
Yamashita, S., Brudvik, K. W., Kopetz, S., Maru, D. M., Clarke, C. N., Passot, G., Conrad, C. H., Chun, Y. S., Aloia, T. A., & Vauthey, J. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000002087 · Cited by 79
Autophagy regulation and its role in gastric cancer and colorectal cancer
Zhou, H.-Y., Yuan, M., Yu, Q., Zhou, X., Min, W., & Gao, D. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160613 · Cited by 77
Aisner, D. L., & Sams, S. B. (2012) · Diagnostic Cytopathology · doi:10.1002/dc.22820 · Cited by 76
Clinical Trials and Progress in Metastatic Colon Cancer
Mody, K., & Bekaii‐Saab, T. (2018) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.11.008 · Cited by 76
Is Complete Liver Resection Without Resection of Synchronous Lung Metastases Justified?
Mise, Y., Kopetz, S., Mehran, R. J., Aloia, T. A., Conrad, C. H., Brudvik, K. W., Taggart, M. W., & Vauthey, J. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4207-3 · Cited by 75
Margonis, G. A., Kim, Y., Sasaki, K., Samaha, M. J., Amini, N., & Pawlik, T. M. (2016) · Cancer · doi:10.1002/cncr.30085 · Cited by 75
Yamashita, S., Sheth, R. A., Niekamp, A., Aloia, T. A., Chun, Y. S., Lee, J. E., Vauthey, J., & Conrad, C. H. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000002018 · Cited by 74
Fujiyoshi, K., Yamamoto, G., Takahashi, A., Arai, Y., Yamada, M., Kakuta, M., Yamaguchi, K., Akagi, Y., Nishimura, Y., Sakamoto, H., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.5323 · Cited by 75
Kawaguchi, Y., Lillemoe, H. A., Panettieri, E., Chun, Y. S., Tzeng, C.-W. D., Aloia, T. A., Kopetz, S., & Vauthey, J. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.04.027 · Cited by 74
Margonis, G. A., Sasaki, K., Kim, Y., Samaha, M. J., Buettner, S., Amini, N., Antoniou, E., & Pawlik, T. M. (2016) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-016-3198-8 · Cited by 73
Biomarkers in colorectal liver metastases
Yamashita, S., Chun, Y. S., Kopetz, S., & Vauthey, J. (2018) · British journal of surgery · doi:10.1002/bjs.10834 · Cited by 72
Han, C., Li, F., Ma, J., & Zou, H. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.732159 · Cited by 74
Genomic landscape of metastatic colorectal cancer
Haan, J. C., Labots, M., Rausch, C. R., Koopman, M., Tol, J., Mekenkamp, L. J., van de Wiel, M. A., Israeli, D., Essen, H. F. H. V., van Grieken, N. C. T., et al. (2014) · Nature Communications · doi:10.1038/ncomms6457 · Cited by 68
Self-citationPredictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases
Passot, G., Chun, Y. S., Kopetz, S., Zorzi, D., Brudvik, K. W., Kim, B. J., Conrad, C. H., Aloia, T. A., & Vauthey, J. (2016) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.12.057 · Cited by 69
Kuo, Y., Chen, J., Fan, C., Li, Y.-S., & Chan, E. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.024 · Cited by 70
Mekenkamp, L. J., Tol, J., Dijkstra, J. R., de Krijger, I., Vink-Börger, M. E., van Vliet, S., Teerenstra, S., Kamping, E. J., Verwiel, E. T. P., Koopman, M., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-292 · Cited by 69
Self-citationColorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach
Blanco, M., Concha, Á., Figueroa, A., Garrido, F., & Valladares‐Ayerbes, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613610 · Cited by 67
Goos, J. A. C. M., de Cuba, E. M. V., Coupé, V. M. H., Diosdado, B., Diemen, P. M. D., Karga, C., Beliën, J. A. M., van Oordt, C. W. M. D. H., Geldof, A. A., Meijer, G. A., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001109 · Cited by 64
Morgan, S. R., Whiteley, J. L., Donald, E. L., Smith, J. C., Eisenberg, M. T., Kallam, E., & Kam-Morgan, L. N. W. (2012) · Clinical Medicine Insights Pathology · doi:10.4137/cpath.s8798 · Cited by 63
Passot, G., Denbo, J. W., Yamashita, S., Kopetz, S., Chun, Y. S., Maru, D. M., Overman, M. J., Brudvik, K. W., Conrad, C. H., Aloia, T. A., et al. (2016) · Surgery · doi:10.1016/j.surg.2016.07.032 · Cited by 63
Lipid metabolism reprogramming in colorectal cancer
Chen, D., Zhou, X., Yan, P., Yang, C., Li, Y., Han, L., & Ren, X. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30347 · Cited by 57
Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis
Neumann, J. H. L., Wehweck, L., Maatz, S., Engel, J., Kirchner, T., & Jung, A. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1450-0 · Cited by 58
Benson, A. B., Arnoletti, J. P., Bekaii‐Saab, T., Chan, E. W., Chen, Y., Choti, M. A., Cooper, H. S., Dilawari, R. A., Engstrom, P. F., Enzinger, P. C., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0104 · Cited by 56
Voutsina, A., Tzardi, M. N., Kalikaki, A., Zafeiriou, Z., Papadimitraki, E., Papadakis, M., Mavroudis, D., & Georgoulias, V. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.150 · Cited by 55
A population genetics perspective on the determinants of intra-tumor heterogeneity
Hu, Z., Sun, R., & Curtis, C. N. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.001 · Cited by 54
Salvatore, L., Aprile, G., Arnoldi, E., Aschele, C., Carnaghi, C., Cosimelli, M., Maiello, E., Normanno, N., Sciallero, S., Valvo, F., et al. (2017) · ESMO Open · doi:10.1136/esmoopen-2016-000147 · Cited by 52
Yamashita, S., Venkatesan, A. M., Mizuno, T., Aloia, T. A., Chun, Y. S., Lee, J. E., Vauthey, J., & Conrad, C. H. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.2986 · Cited by 51
Management of resectable colorectal lung metastases
Moorcraft, S. Y., Ladas, G., Bowcock, A. M., & Chau, I. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9774-6 · Cited by 49
Jahangiri, L., & Hurst, T. P. (2019) · Cancers · doi:10.3390/cancers11121938 · Cited by 50
Atreya, C. E., Sangale, Z., Xu, N., Matli, M. R., Tikishvili, E., Welbourn, W., Stone, S., Shokat, K. M., & Warren, R. S. (2013) · Cancer Medicine · doi:10.1002/cam4.97 · Cited by 52
Raimondi, C., Nicolazzo, C., Gradilone, A., Giannini, G., FALCO, E. D., Chimenti, I., Varriale, E., Hauch, S., Plappert, L., Cortesi, E., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28020 · Cited by 47
Yamashita, S., Chun, Y.-S., Kopetz, S., Maru, D. M., Conrad, C. H., Aloia, T. A., & Vauthey, J. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002245 · Cited by 47
Furuki, H., Yamada, T., Takahashi, G., Iwai, T., Koizumi, M., Shinji, S., Yokoyama, Y., Takeda, K., Taniai, N., & Uchida, E. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2018.01.224 · Cited by 46
Lord, A. C., Moran, B. J., Abulafi, M., Rasheed, S., Nagtegaal, I. D., Terlizzo, M., & Brown, G. M. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033395 · Cited by 44
Self-citationMolecular Testing in Colorectal Cancer
Shi, C., & Washington, K. M. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcpi83dinulujni · Cited by 43
Takeda, K., Yamada, T., Takahashi, G., Iwai, T., Ueda, K., Kuriyama, S., Koizumi, M., Matsuda, A., Shinji, S., Ohta, R., et al. (2019) · Cancer Science · doi:10.1111/cas.14186 · Cited by 42
Ferreira, C. G., Aran, V., Zalcberg-Renault, I., Victorino, A. P., Salem, J. H., Bonamino, M., Vieira, F. M. D. A. C., & Zalis, M. G. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-73 · Cited by 41
Precision treatment for cancer: Role of prognostic and predictive markers
Duffy, M. J., & Crown, J. P. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.865700 · Cited by 41
Jesinghaus, M., Wolf, T. A., Pfarr, N., Muckenhuber, A., Ahadova, A., Warth, A., Goeppert, B. F., Sers, C., Kloor, M., Endris, V., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000423 · Cited by 39
Mogensen, M. B., Rossing, M., Østrup, O., Larsen, P. N., Engel, P. J. H., Jørgensen, L. N., Høgdall, E. V. S., Eriksen, J., Ibsen, P. H., Jess, P., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4639-4 · Cited by 41
Stegeman, H., Kaanders, J. H. A. M., van der Kogel, A. J., Iida, M., Wheeler, D. L., Span, P. N., & Bussink, J. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.02.001 · Cited by 38
RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer
Waring, P. M., Tie, J., Maru, D. M., & Karapetis, C. S. (2015) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2015.10.006 · Cited by 41
RAS mutation: site of disease and recurrence pattern in colorectal cancer
Bonnot, P., & Passot, G. (2019) · Chinese Clinical Oncology · doi:10.21037/cco.2019.08.11 · Cited by 37
Metadata
- Authors
- Knijn, N., Mekenkamp, L. J. M., Klomp, M., Vink-Börger, M. E., Tol, J., Teerenstra, S., Meijer, J. W. R., Tebar, M., Riemersma, S., van Krieken, J. H. J. M., Punt, C. J. A., & Nagtegaal, I. D.
- Affiliations
- Radboud University Medical Center (NL)
- Rijnstate Hospital (NL)
- Corresponding author
- Nagtegaal, I D
- Venue
- British Journal of Cancer
- Published
- 2011-03
- Volume
- 104
- Issue
- 6
- Pages
- 1020-1026
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC3065268
- OpenAlex
- W2011288277
- Cited by
- 291
- References
- 34
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 5 · 2023: 11 · 2022: 8 · 2021: 15 · 2020: 21 · 2019: 20 · 2018: 20 · 2017: 30 · 2016: 31 · 2015: 24 · 2014: 33 · 2013: 21 · 2012: 34
- FWCI
- 14.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Dutch Colorectal Cancer Group
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- KRAS mutation, colorectal cancer, liver metastasis, primary tumor, codon 12 and 13 mutations, anti-EGFR antibody therapy, predictive biomarkers
- MeSH terms
- Aged, Carcinoma, DNA Mutational Analysis, Female, Humans, Liver Neoplasms, Male, Middle Aged, Models, Biological, Mutation, Genes, ras, Colorectal Neoplasms, Cohort Studies, Multicenter Studies as Topic, Matched-Pair Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
